Concepedia

Shuhei Osaki

SO

Statistics

Publications

5

Citations

146

H-Index

5

Active since

2012

Affiliations

Okayama University Hospital(Current)

Oncolys BioPharma (Japan)

Okayama University

Shuhei Osaki is an author at Okayama University Hospital specializing in oncology, cancer therapeutics, and tumor biology.

ORCID

Top concepts

Publications per year

2012–2021

5

Publications

5

Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells

Joe Hasei, Tsuyoshi Sasaki, Hiroshi Tazawa et al. · Molecular Cancer Therapeutics · 2013 · 61 citations

Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas

Shuhei Osaki, Hiroshi Tazawa, Joe Hasei et al. · Scientific Reports · 2016 · 45 citations · Full text

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction

Yasuaki Yamakawa, Hiroshi Tazawa, Joe Hasei et al. · Cancer Science · 2017 · 14 citations · Full text

Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression

Kazuhisa Sugiu, Hiroshi Tazawa, Joe Hasei et al. · Cancer Chemotherapy and Pharmacology · 2021 · 14 citations

, , +7

A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus

Tsuyoshi Sasaki, Hiroshi Tazawa, Joe Hasei et al. · Gene Therapy · 2012 · 12 citations

, , +7

1–5 of 5